Elsevier

Brain Research

Volume 720, Issues 1–2, 13 May 1996, Pages 75-83
Brain Research

Research report
Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis

https://doi.org/10.1016/0006-8993(96)00142-4Get rights and content

Abstract

Increased permeability of the blood-brain (B-B) barrier is observed during meningitis. Preventing B-B barrier alterations is important because adverse neurological outcomes are correlated with breeches in barrier integrity. It was hypothesized that pathological production of nitric oxide (NO) contributes to B-B barrier disruption during meningitis in the rat. Experimental meningitis was induced by intracisternal (i.c.) administration of lipopolysaccharides (LPS) or vehicle. Groups of rats were concomitantly infused intravenously (i.v.) with saline or the NO synthase inhibitor, aminoguanidine (AG). Eight h after i.c. dosing, B-B barrier alterations were quantitated pharmacokinetically using [14C]sucrose. Serum and regional brain tissues were obtained 0–30 min after tracer dosing and sucrose influx transfer coefficients ( Kin (app)) were calculated from the brain tissue data. Compared to the control groups (i.c. vehicle/i.v. saline), the Kin (app) of the i.c. LPS/i.v. saline group increased 1.6–2.1-fold in various brain regions, thus confirming previous observations of increased [14C]sucrose barrier penetration during meningeal inflammation. Remarkably, i.v. administration of AG to i.c. LPS-treated rats significantly inhibited meningeal NO synthesis and decreased Kin (app) permeability alterations in the B-B barrier, compared to i.c. LPS/i.v. saline-treated rats. Regional brain Kin (app) estimates in the i.c. LPS/i.v. AG group were similar to control groups (i.c. vehicle/i.v. AG and i.c. vehicle/i.v. saline). In conclusion, these data suggest the general concept that excessive NO production during neuroinflammatory diseases contributes to disruption of the blood-brain barrier.

References (76)

  • NowickiJ.P. et al.

    Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse

    Eur. J. Pharmacol.

    (1991)
  • RadiR. et al.

    Peroxyni-trite oxidation of sulfhydryls: The cytotoxic potential of Superoxide and nitric oxide

    J. Biol. Chem.

    (1991)
  • SmithQ.R. et al.

    Kinet-ics and distribution volumes for tracers of different sizes in the brain plasma space

    Brain Res.

    (1988)
  • WolffD.J. et al.

    Aminoguanidine is an isoform-selec-tive mechanism-based inactivator of nitric oxide synthase

    Arch. Biochem. Biophys.

    (1995)
  • BarinagaM.

    Antibodies linked to rare epilepsy

    Science

    (1995)
  • BeavenM.A. et al.

    A specific and sensitive assay for aminoguanidine: Its application to a study of the disposition of aminoguanidine in animal tissues

    J. Pharmacol. Exp. Ther.

    (1969)
  • BeckmanJ.S. et al.

    Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and Superoxide

  • L. et al.

    Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

    Ann. Neurol.

    (1994)
  • BojeK.M.K.

    Cerebrovascular permeability changes during experi-mental meningitis in the rat

    J. Pharmacol. Exp. Ther.

    (1995)
  • BredtD.S. et al.

    Nitric oxide mediates glutamate-lin-ked enhancement of cGMP levels in the cerebellum

  • BredtD.S. et al.

    Isolation of nitric oxide synthetase a calmodulin-requiring enzyme

  • BredtD.S. et al.

    Cloned and expressed nitric oxide synthase struc-turally resembles cytochrome P-450 reductase

    Nature.

    (1991)
  • BrosnanC.F. et al.

    Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species

    Neurology.

    (1995)
  • CampbellI.L. et al.

    Expression of the inducible nitric oxide synthase: Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis

    J. Immunol.

    (1994)
  • CorbettJ.A. et al.

    Aminoguanidine a novel inhibitor of nitric oxide formation prevents diabetic vascular dysfunction

    Diabetes

    (1992)
  • CrossA.H. et al.

    Aminoguanidine. an inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune encephalomyelitis is SJL mice

    J. Clin. Invest.

    (1994)
  • DawsonT.M. et al.

    Nitric oxide: Actions and patho-logical roles

    Neuroscientist

    (1995)
  • DingA. et al.

    Macrophage deactivating factor and transforming growth factors-β1-β2 and-β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ

    J. Immunol.

    (1990)
  • EverettN.B. et al.

    Distribution of blood (Fe59) and plasma (I131) volumes of rats determined by liquid nitrogen freezing

    Circ. Res.

    (1956)
  • GarthwaiteJ. et al.

    Endothelium-derived relaxing factor on activation of NMDA receptors suggests role as intercellular messenger in the brain

    Nature

    (1988)
  • GreenwoodJ.

    Mechanisms of blood-brain barrier breakdown

    Neuroradiology

    (1991)
  • GriffithsM.J.D. et al.

    MacAllister R.J. and Evans T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase

    Br. J. Pharmacol.

    (1993)
  • HaberlR.L. et al.

    Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?

    Neurol. Res.

    (1994)
  • HauschildtS. et al.

    L-arginine-dependent nitric oxide formation and nitrite release in bone marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide

    Immunology

    (1990)
  • HooperD.C. et al.

    Local nitric oxide production in viral and autoimmune diseases of the central nervous system

  • IkedaM. et al.

    Cyclic guanosine monophosphate (cGMP) nitrite and nitrate in the cerebrospinal fluid in meningitis multiple sclerosis and guillaine-barre syndrome

    Intern. Med.

    (1995)
  • JangroD. et al.

    Regulation of blood-brain barrier endothelial cells by nitric oxide

    Circ. Res.

    (1994)
  • JenkinsD.C. et al.

    Roles of nitric oxide in tumor growth

  • Cited by (105)

    • Toxocara-induced neural larva migrans (neurotoxocarosis) in rodent model hosts

      2020, Advances in Parasitology
      Citation Excerpt :

      Beside microglia activation, elevated glial fibrillary acidic protein (GFAP)-expression has been detected by immunohistochemistry, providing evidence for astrocytic activation and reactive astrogliosis in the cerebral parenchyma (Eid et al., 2015; Liao et al., 2008; Othman et al., 2010). Furthermore, T. canis-infection causes an elevated expression of inducible nitric oxide synthase (iNOS) in glial cells, which can have detrimental effects on the brain if produced in excess (Boje, 1996; Gargili et al., 2004; Liao et al., 2008; Othman et al., 2010). Neuroinflammatory processes are initiated by potent pro-inflammatory cytokines, e.g., TNF-α, interferon (IFN)-γ and IL-6, but excessive or inappropriate neuroinflammatory reactions may be detrimental for cerebral tissues.

    • Acute Meningitis

      2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
    • Critical role of TRPP2 and TRPC1 channels in stretch-induced injury of blood-brain barrier endothelial cells

      2012, Brain Research
      Citation Excerpt :

      Our current studies demonstrate that stretch-induced activation of TRPC1 and TRPP2 lead to both a rapid activation of calcium influx that, in turn, leads to activation of eNOS and the generation of NO. Both elevated cytosolic calcium levels and NO levels likely contribute to altered endothelial functions under these conditions and loss of integrity of the endothelial barrier. Indeed accumulating evidence points to an NO-mediated modulation of barrier permeability in endothelial cells (Boje, 1996; Boueiz and Hassoun, 2009), including mechanisms involving actin-cytoskeleton modifications (Shen et al., 2010; Yuan et al., 1997). Further, several TBI studies have reported a rise of NO levels shortly after injury which may contribute to barrier breakdown (Rao et al., 1998; Wada et al., 1998).

    • Contribution of nitric oxide synthase (NOS) in blood-brain barrier disruption during acute focal cerebral ischemia in normal rat

      2012, Pathophysiology
      Citation Excerpt :

      Although, disruption of BBB integrity due to ischemic/reperfusion (I/R) injury during stroke is well documented [3,12], data about the involvement of NO are conflicting. Some reports have demonstrated that the inhibition of nitric oxide synthase (NOS) activity by l-NAME diminished acute ischemic brain damage by reducing BBB disruption [12,13]. Whereas, others have revealed that the administrations of l-arginine, NO substrate, reduced ischemic brain damages by endorsing NO-dependent vasodilatation pathway and increasing regional cerebral blood flow (rCBF) [14–16], whereas others believe it augmented ischemic neural damages by increasing tissue NO production [17].

    View all citing articles on Scopus
    View full text